メドトニックは第2四半期の予想を上回り 2026年の予測を上げ 配当を増加させた Medtronic beat Q2 earnings estimates, raised 2026 guidance, and increased its dividend.

いくつかの機関投資家は第2四半期にMedtronic PLC (MDT) の持分を調整し,Bartlett & CO.とHardman Johnstonは持分を削減し,ヒルトップ・ナショナル・バンクとマッテン・キャピタル・マネジメントは持分を増加させた. Several institutional investors adjusted their stakes in Medtronic PLC (MDT) during the second quarter, with Bartlett & CO. and Hardman Johnston reducing holdings, while Hilltop National Bank and Mattern Capital Management increased theirs. 同社は8月19日に2四半期に強い利益を報告し,推定額を上回る1.26ドルのEPSを出し,8.58億ドルの収益を上げ,同比7.7%増加した. The company reported strong Q2 earnings on August 19, posting $1.26 EPS, surpassing estimates, and $8.58 billion in revenue, up 7.7% year-over-year. メドトニックは2026年度の利益予測を1株当たり5.60ドルから5.66ドルに上げ,3.0%の利回りとなる0.71ドルの四半期配当を宣言した. Medtronic raised its fiscal 2026 earnings guidance to $5.60–$5.66 per share and declared a quarterly dividend of $0.71, yielding 3.0%. 株式は95.57ドルで取引され,市場資本は22.590億円,P/e比は26.33ドル,合意の"モデレートバイヤー"評価と目標価格は102.27ドル. The stock traded at $95.57, with a market cap of $122.59 billion, a P/E ratio of 26.33, and a consensus "Moderate Buy" rating and target price of $102.27.